Member Info for fulmar29

that they have released news before paying themselves in shares again speaks volumes.Anyone who is impatient now,will be inconsolable by the end of the year.--2019 is action year IMO GLA if you are patient.If you are not,exercise your options.

Yes you are right ,I posted an apology here for "wrong board" but it hasn't shown up.Whatever "sorry all"-a senior moment.

Cobalt Miners News For The Month Of March 2018 Mar. 25, 2018 2:26 Matt Bohlsen Investment advisor, portfolio strategy, growth at reasonable price MARKETPLACETrend Investing (10,276 followers) Summary Cobalt spot price news - Spot prices rise 18.7% in the past month as inventory falls. The cobalt spot price is now over USD 40/lb, and approaching USD 100,000/tonne. Cobalt market news - China leaving West behind in race for electric-car raw materials. Battery makers descend on Australia, Canada cobalt developers. Design News - "Cobalt will remain an expensive but necessary ingredient in our battery energy future." VW secures $25 billion battery supplies in electric-car surge. Cobalt miner news - China's GEM had agreed to buy 52,000 tonnes of cobalt from Glencore over 3 years. Welcome to the March 2018 cobalt miner news. For some background on the cobalt miners, please check out my earlier articles: May 2016 - "Cobalt Miners Set To Boom" December 2016 - "A Look At The Junior Cobalt Miners" December 2016 - "Top 5 Cobalt Miners To Consider" March 2017 - "Top 3 Cobalt Miners To Accumulate" September 2017 - "Top 3 Cobalt Juniors To Consider" January 2018 - "3 Well-Valued Cobalt Miners To Buy Right Now" The past month has indeed seen the great cobalt rush intensify, triggered in part by Volkswagen (OTCPK:VLKAY) (more below). Or as Cobalt Blue (OTCPK:CBBHF) CEO Joe Kaderavek says - �We are starting to see the first signs of an arms race to secure long term cobalt supplies.� Added to this, cobalt prices moved above USD 40/lb and is fast approaching USD 100,000/tonne. The deal fever was kicked off this month with Volkswagen announcing a stunning $25b battery supply deal from Samsung SDI Co., LG Chem Ltd. and Contemporary Amperex Technology Ltd [CATL]. Then Samsung C&T Corp (an affiliate of Samsung (OTC:SSNLF)) announced it is working on a cobalt deal with Somika SPRL, followed by China's GEM large cobalt deal with Glencore (OTCPK:GLNCY), and finally Cobalt Blue announced a new strategic partnership with LG. This follows the recent SK Innovation deal with Australia Mines. What a month! Cobalt price news As of March 22, the cobalt spot price was US$43.09, an 18.7% increase from US$36.29 this time last month. The LME cobalt price has now reached ~95,000/tonne and is closing in on USD 100,000/tonne. The London Metals Exchange [LME] inventory has continued to fall and is slightly lower this month (see graph below). Like this article page 1 / 19 | Next �

on ABM is relevant here to Zam. Chinese control of cobalt supply is risk for car industry: Glencore Julia Payne, Dmitry Zhdannikov LAUSANNE, Switzerland (Reuters) - The automotive industry is waking up too late to the fact that China will hold most of the world�s supply of cobalt, a key metal for electric vehicle (EV) batteries, Glencore Chief Executive Ivan Glasenberg said on Tuesday. �If cobalt falls into the hands of the Chinese, yeah you won�t see EVs being produced in Europe etc. They are waking up too late ... I think it�s because the car industry has never had a supply chain problem before,� Glasenberg told the FT Commodities Global Summit in Lausanne, Switzerland. Glasenberg said he was nevertheless prepared to sell cobalt mines in the Democratic Republic of Congo to China if the price was good. He added that the company was not changing its production plans in the DRC. More than 60 percent of global cobalt production comes from the DRC. Glencore, the world�s biggest producer, agreed last week to sell a third of its output to China�s GEM. GEM and its subsidiaries will buy 13,800 tonnes of cobalt from Glencore this year, 18,000 tonnes next year and 21,000 tonnes in 2020. The Swiss-based miner is expected to produce about 39,000 tonnes this year or about 35 percent of the global total, estimated at 110,000 tonnes by analysts. A byproduct of copper and nickel smelting, cobalt extends the life of rechargeable lithium-ion batteries, which automakers typically guarantee for eight to 10 years. Expectations of supply shortages have fueled a rally that has taken prices to around $39 a lb, from near $10 a lb in January 2016 and to their highest since July 2008, before the financial crisis started. Reuters reported last year that Chinese battery maker Contemporary Amperex Technology Co Ltd (CATL) had agreed a deal late in 2016 to buy large amounts of cobalt from Glencore. CATL�s listing prospectus published last year names Glencore as a top-five supplier

I hope this trial was done with an order to follow the successful trial ,otherwise what's the point in a trial ?

shot should have read shout but also maybe relevant

Nomenee should have read nominee but quite funny as I am about to have the left one replaced on fri and might shot that afterwards.(nomiknee)

Just made a few enquiries and found out that NEX operates separately to London Stock Ex,so a trade from any nomenee acc holder could execute on either or both.I like things simple-That ain't !

as well as wondering why only one would show on the main ledger.

Yes

SGD27-both traded through LSE First trade showing on LSE here ,but second trade only showing on NEX-Anyone explain ?

Hi Dub. I could be completely wrong but the facts speak for this share.And I think its no co incidence TYM is similarly structured and in similar market type i.e. non precious base metal extraction (obviously same management),and when TYM has had it's little run,they will then turn to SRES-it seems to be an emerging pattern,and as I have said here before I believe the destiny of both companies is entwined.GLA

this morning and the first showed up,and the second which was moments later (at a slightly higher price) is yet to appear.Strange how trades can show up or not selectively ! So to all those people who say the MMs do not manipulate ,you need to rethink your views.Share trades should be obvious and transparent.

JJ why converse with it ?just filter it.I have reported it and now filtered.I really enjoy alternative views,but when they are just dumb postings,with no factual information and no effort to inform then they just need to be ignored.When you answer it's dumb posts,you are doing what it needs.

Totally agree mineralex,we have a low cost low effort "Bread and Butter" mining asset that will finance something much,much bigger.The Mcap will be lifted to reflect the initial mine asset,but I will hold to see what the next mine will be.

not a fast buck but I still believe SSL will double and more by the time the HM effect happens-this snippet seems to bear this out. Michael Murphy, New World Investor Most likely, gold needs one more retracement before a third -- and successful -- attempt to break $1,356 and reignite the gold bull market. Vancouver-based Sandstorm Gold (SAND) provides financing for precious metal mining companies. Known as a royalty streaming company, Sandstorm earns a percentage of gold product in exchange for upfront financing. The stock sold off 10% after its latest earnings report, booked $15.4 million in revenues, had $9.9 million in operating cash flow, and reported break-even earnings per share. There were a number of one-time credits and charges. They repeated their forecast for 50,000 to 60,000 ounces of gold equivalent production in 2018, growing to 125,000 ounces in 2022. I think investors over-reacted to the one-time issues like foreign exchange fluctuations and non-cash impairment charges. They also don't like the share dilution that is necessary because SAND is in a rapid growth phase. On the conference call, management pointed out that 2017 was a record year for both total attributable gold equivalent ounces sold (over 54,000 ounces) and revenues (over $68 million). They acquired another 39 royalties, bringing the total to 174 streams and royalties. The most recent acquisition is a 2% net smelter royalty on Endeavour's Hounde mine in Burkina Faso. This royalty was purchased for $45 million and based on Endeavour's guidance, Sandstorm's 2% of revenue should be about $6 million in 2018. Because they paid for the acquisition with a combination of $10 million in cash on hand and $35 million from the revolving debt facility, the acquisition will be materially accretive to cash flow per share because they didn't issue any shares to do the acquisition. As for the debt, because of the sale of Equinox securities as well as strong cash flow so far this year, they already repaid the debt down to $7.5 million and expect it to be paid to zero and start rebuilding their cash position by next quarter. In only a couple of months, the new $150 million revolving debt facility will be totally undrawn and can be used for future acquisitions. This is the kind of management we want shepherding our investment! CEO Nolan Watson said: "I really do believe that for the first time in nearly a decade, we're in a win-win situation for gold. Yes, there will be lots of volatility, including volatility in the gold price, but with a strong balance sheet and low fixed operating costs, we're in a position to profit from that volatility instead of being afraid of it." They expect to start paying dividends in 2019. Sandstorm Gold is one of the very best ways to get leveraged exposure to precious metals. I urge you to take advantage of the post-earnings weakness to build a position. George Putnam, The Turnaround Letter

from Trump on II.As the following is offered as a discussion document, I wonder how differently others see the competition for a MED2002 license playing out? Feel free to rip it to bits, but please try to leave something constructive behind. Background It has been many years since a large Pharma showed interest in CSD500. Futura worked well with SSL International to develop and commercialise this condom, but when RB became involved, they sidelined CSD500, then tried to renegotiate the agreement terms, and things unwound swiftly thereafter. RB went on to take the Chinese condom market by storm, C+D wasted time licensing USA and parts of Europe, but eventually returned the rights. The biggest condom distributors are well aware of CSD500, but have so far not taken any interest they might have any further. MED2002 License Competition There is much competition to become the selected licensing partner for MED2002, and that partner will likely insert a contract clause providing the partner with options to buy either MED2002 or FUM. The possibility for a number of regional MED2002 deals was only vaguely discussed in recent RNS's, but all parties are accutely aware that another bonanza, appreciably bigger than that which surrounded Viagra and Cialis is the prize for the owner of the MED2002 patent. The last RNS revealed that some interested parties wanted to license both CSD500 and MED2002, and that they might want a regional deal. The reality might be that what was discussed was a global deal. I therefore suggest that some of those parties are using an interest in licensing CSD500, to remain on FUM's short list of most suitable partners for the MED2002 license. At this point, I assume that FUM have already stated that they want the Phase III trial costs to be met by the licensee. We do not know how the competition to remain on FUM's short list might develop. However, competing Pharma might : 1 Offer money to complete Phase III testing of Pain Killers, with a view to purchase or license TIB and TPR products, additional to a MED2002/CSD500 license. The US pain killer market is ripe for ways to deliver non-addictive pain relief. If it is necessary to show interest in all three products however, surely a strait cash offer for the company makes more sense, subsequently selling off any products that are not of interest. 2 Offer to license Dermasys to deliver tried and tested drugs in their own catalogue topically and more efficiently, reducing or possibly eliminating side effects from the systemic application of present drugs. This might allow FUM to benefit from royalty payments, or trigger new patent applications to the longer term benefit of FUM. In short, competing pharma must at all costs find ways to stay on the short list. JB has indicated little of the behind the scenes manoeuvring currently in play I think. It seems that more offers are likely, - possibly when the PK studies are released?

https://flipboard.com/@flipboard/-big-pharmas-under-increasing-pressure-a/f-1f544f915b%2Fbusinessinsider.com pinched from the val site

Sod RB ! my guess is PC is looking elsewhere and RB (who are losing share daily on Viagra) will lose even more when our products eventually hit the market.I also believe at the merest sniff of PC doing a deal with someone,RB may well be forced into a bidding/takeover war ,as a competitor would take large chunks out of their profits with our products GLA

if we have detection of filter equipment that can remove plastic particles today ?